期刊文献+

影响脑干胶质瘤放射治疗预后的相关因素分析 被引量:6

Prognostic factors analysis of brainstem glioma
原文传递
导出
摘要 目的回顾性分析放射治疗的脑干胶质瘤病例,探讨肿瘤的预后及其影响因素。方法2009年7月至2011年12月收治病理确诊的脑干胶质瘤患者54例,随访患者总生存率,对相关指标进行单因素及多因素分析,运用预后指数模型综合评价放疗疗效。结果全组患者中位生存时间17.5个月,1年、3年总生存率分别为83%和61%。单因素及多因素分析显示WHO低分级、病灶局限于单一解剖部位的患者预后较好P〈0.05。预后指数能够更好的预测脑干胶质瘤患者的预后。结论WHO分级及病灶是否局限于单一解剖结构有可能成为脑干胶质瘤放射治疗的独立预后因素,预后指数模型能够显著提高多指标联合的预测价值。 Objective A retrospective analysis was carried out to evaluate the prognosis and Influence factors of brain stem gliomas (BSG). Methods From Jul. 2009 to Dec. 2011, 54 patients with pathological diagnosis of WHOⅠ-Ⅳ BSG received definitive radiotherapy and eligible for the analysis. In all patients, 21 cases accepted subtotal resection,27 cases accepted partial resection and 6 accepted biopsy; 16 cases accepted intensity- modulated radiation therapy (IMRT) and 38 cases accepted three dimensional radiotherapy(3DCRT ) , 1.8-2.0 Gy/f ,total dose(DT) was 45 -60 Gy, the median DT was 50.4 Gy; 24 cases accepted concurrent chemoradiotherapy of temozolomide and 30 cases accepted radiation alone. The significance of related prognostic factors were evaluated by univariate and multivariate analysis. The value of each prognostic factor in the survival was added up to calculate the prognostic index(PI). Results In all patients, the median survival time was 17. 5 months. The overall survival rate of 1 year and 3 year was 83% and 61%, respectively. Univariate and multivariate analysis showed that with a low WHO grade and lesion confined to a single anatomic site gave a better survival. Conclusion Low WHO grade and lesion confined to a single anatomic site are likely to be independent prognostic factors. Prognostic index model can predict the prognosis of BSG more effectively than single variable.
出处 《中华神经外科杂志》 CSCD 北大核心 2013年第11期1093-1096,共4页 Chinese Journal of Neurosurgery
关键词 脑干胶质瘤 放射治疗 替莫唑胺 预后 Brain stem gliomas Radiotherapy Temozolomide Prognosis
  • 相关文献

参考文献11

  • 1Guillamol JS, Monjour A, Taillandier L, et al. Brainstem glio- 8mas in adults: prognostic factors and classification. Brain , 2001, 124: 2528-2539.
  • 2李德志,阴鲁鑫,郝淑煜,吴震,李大鹏,王宇,万伟庆,武文浩,田永吉,张俊廷,张力伟,王忠诚.134例脑干胶质瘤的临床特征及预后分析[J].中华神经外科杂志,2009,25(10):867-870. 被引量:23
  • 3Karim AB, Afra D, Comu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys , 2002, 52:316-324.
  • 4Bernier-Chastagner V, Grill J, Doz F, et al. Topotecan as a radiosensitizer in the treatment of children with malignant diffuse brainstem gliomas: results of a French Society of Paediatric Oncology Phase II Study. Cancer, 2005,104:2792-2797.
  • 5Marcus K J, Dutton SC, Barnes P, et al. A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma. Int J Radiat Oncol Biol Phys , 2003, 55: 1182-1185.
  • 6Freeman CR, Kepner J, Kun LE, et al. A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas? . Int J Radiat Oncol Biol Phys, 2000, 47:561-564.
  • 7Doz F, Neuenschwander S, Bouffet E, et al. Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaised Oncologie Pediatrique. Eur J Cancer, 2002, 38:815-819.
  • 8Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 2005, 352:987-996.
  • 9Stupp R, Hegi ME, Mason WP, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomized phase 111 study : 5-year analysis of the EORTC-NCIC trial. Lancet Oncol , 2009, 10:459-466.
  • 10Huang P, Chen Y, Wang T, et al. Concurrent Radiotherapy and Temozolomide for Pediatric Brain Stem Gliomas. lnt J Radiat Oneol Biol Phys, 2009 , 75(Suppl) :S515-S516.

二级参考文献22

  • 1王忠诚,张俊廷,刘阿力.311例脑干胶质瘤的临床特征与手术治疗[J].中国医学科学院学报,2005,27(1):7-12. 被引量:34
  • 2夏云飞.儿童脑干胶质瘤的放射治疗[J].广东医学,2005,26(9):1176-1177. 被引量:4
  • 3王向宇,柯以铨,王清华,徐如祥.脑干占位病变治疗及相关问题探讨[J].中华神经医学杂志,2005,4(10):1028-1031. 被引量:5
  • 4Recinos PF,Sciubba DM,Jallo GI.Bminstem tumors:where are we today?Pediatr Neumsurg,2007,43:192-201.
  • 5Albright AL,Packer RJ,Zimmerman R,et al.Magneticresonance scans should replace biopsies for the diagnosis of diffuse brain stem gliomas:a report from the Children's cancer group.Neurosurgery,1993,33:1026-1029;discussion 1029-1030.
  • 6Chamberlain MC.Adult brainstem gliomas.Neurology,1999,53:437-438.
  • 7Kesari S,Kim RS,Markos V,et al.Prognostic factors in adult brainstem gliomas:a multicenter,retrospective analysis of 101 cases.J Neurooncol,2008,88:175-183.
  • 8Guillamo JS,Monjour A,Taillandier L,et al.Brainstem gliomas in adults:prognostic factors and classification.Brain,2001,124(Pt 12):2528-2539.
  • 9Yeh DD,Warnick RE,Ernst RJ,et al.Management strategy for adult patients with dorsal midbrain gliomas.Neurosurgery,2002,50:735-738.
  • 10Farmer JP,Montes JL,Freeman CR,et al.Brainstem gliomas.A 10-year institutional review.Pediatr Neurosurg,2001,34:206-214.

共引文献22

同被引文献59

  • 1Kreth FW, Thon N, Simon M, et al. Gross total but not incomplete re-section of glioblastoma prolongs survival in the era of radiochemotherapy[J]. Ann Oncol, 2013 ,24( 12) :3117-3123.
  • 2Julia R,Eric B,Diana S. A multi - centre Canadian pilot study of metro-nomic temozolomide combined with radiotherapy for newly diagnosed pae-diatric brainstem glioma[ J]. Eur J Cancer, 2010,78(24) :769 - 776.
  • 3Rapp M, Goeppert M, Felsherg J, et al. The impact of sequential vs.combined radiochemotherapy with temozolomide, resection and MGMTprometer hypermethylation on survival of patients with primary glipblasto-ma-a single centre retrospective study [J]. Br J Neurosurg, 2013,32(27):430-436.
  • 4Salmaggi A, Fariselli L,Milanesi I, et al. Natural history and manage-ment of brainstem gliomas in adults. A retrospective Italian study [ J].Neurol, 2009,255(2):171 -177.
  • 5林清,金冶宁,吴国华.恶性脑胶质瘤的化疗以及与放疗的相互作用[J].中国肿瘤临床与康复,2007,14(6):560-562. 被引量:5
  • 6Chen AM, Farwell DG,Luu Q, et al. Intensity-modulated radio- therapy is associated with improved global quality of life among tong-tel survivors of head-and-neck cancer [ J]. Int J Radiat Oncol Biol Phys, 2012, 84:170-175.
  • 7Cho KH, Kim JY, Lee SH, et al. Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade glio- mas[ J]. Int J Radiat Oncol Biol Phys, 2010, 78:390-397.
  • 8Cao JQ, Fisher BJ, Bauman GS, et al. Hypofractionated radio- therapy with or without concurrent temozolomide in elderly pa- tients with glioblastoma multiforme: a review of ten-year single institution',d experience[ J]. J Neurooncol, 2012,107:395- 405.
  • 9Panet-Raymond V,Souhanfi L, Roberge D,et al. Accelerated hy- pofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multi- forme :a safety and efficacy analysis[J]. Int J Radiat Oncot Biol Phys, 2009, 73:473-478.
  • 10McCrea HJ, Bander ED, Venn RA, eta|. Sex, age, anatomic lo- cation, and extent of resection influence outcomes in children with high-grade glioma[ J]. Neurosurgery, 2015, 77:443-452.

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部